The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
(Reuters) -Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
Novavax ( NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this ...
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
Sanofi will pay $500 million up front to Novavax for the right to co-commercialize Nuvaxovid worldwide (except in a few ...
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...
The Biden administration's new tariffs on Chinese electric vehicles and other strategic sectors aim to protect the future of ...
Novavax (NVAX) stock as Shah Capital withdraws its proxy campaign against the company following a licensing agreement with ...